Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
NCT ID:
NCT00224757
Eligibility Criteria:
Inclusion Criteria:
* Documented atrial fibrillation or atrial flutter, paroxysmal or permanent
* Conventional indication for VKA treatment
* Signed informed consent
Exclusion Criteria:
* Planned electro cardioversion
* Very high risk of TE (previous ischemic stroke or systemic TE, symptoms of heart failure or left ventricular dysfunction, mitral valve stenosis, hypertrophic cardiomyopathy)
* Indication for VKA treatment other than atrial fibrillation (e.g. mechanic valve prosthesis)
* Atrial fibrillation secondary to reversible diseases (e.g. thyrotoxicosis)
* Contraindication for treatment with VKA, aspirin, or clopidogrel
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00224757
Study Brief:
Protocol Section:
NCT00224757